DUBLIN--(BUSINESS WIRE)--The "Coagulation Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Coagulation Testing Market to Reach $3.8 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Coagulation Testing estimated at US$2.7 Billion in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 5.1% CAGR and reach US$3.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 3.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $742.5 Million, While China is Forecast to Grow at 7.2% CAGR
The Coagulation Testing market in the U.S. is estimated at US$742.5 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$778.1 Million by the year 2027 trailing a CAGR of 7.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.
Select Competitors (Total 38 Featured) -
- Abbott Laboratories, Inc.
- Agappe Diagnostics Ltd.
- Alere, Inc.
- F. Hoffmann-La Roche AG
- Helena Laboratories, Inc.
- HemoSonics, LLC
- Horiba, Ltd.
- Medtronic PLC
- Randox Laboratories Ltd.
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
- Universal Biosensors Inc.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/82myiu
